AUS
NZ
UK
CA
USA
IND
Healthcare
4DMedical Collaborates with Philips to Enhance Lung Imaging Technology
September 27, 2024 10:30 AM AEST| By Team Kalkine MediaHighlights,4DMedical signs reseller deal with Philips for US distribution.,Agreement aims to enhance lung imaging technology for veterans.,Partnership focuses on addressing respiratory diseases linked to military service.,4DMedical Ltd (ASX:4DX) has...
ASX Biotech Stocks Show Dynamic Developments
September 26, 2024 06:03 PM AEST| By Team Kalkine MediaHighlights,PYC Therapeutics highlights a significant valuation gap between late-stage and early-stage biotech companies.,OncoSil Medical reaches halfway in patient recruitment for pancreatic cancer trials, showcasing progress in its targeted radiatio...
Promising Trends in the Australian Healthcare Sector Post-FY24
September 26, 2024 11:08 AM AEST| By Team Kalkine MediaSummary Points,The Australian healthcare sector displays positive trends post-FY24 reporting, with rising revenue and margins among ASX-listed firms.,Companies like ResMed and CSL are gaining momentum, though challenges remain in pathology and aged c...
Southeast Asia Emerging as a Key Market for ASX Health Stocks
September 26, 2024 11:06 AM AEST| By Team Kalkine MediaSummary Points,Southeast Asia's aging population and growing middle class create significant opportunities for ASX health stocks.,Several Australian healthcare companies, including EZZ Life Science and Recce Pharmaceuticals, are expanding their prese...
Sigma Healthcare (ASX: SIG) Sees Earnings Drop from Chemist Warehouse Merger Costs
September 26, 2024 10:07 AM AEST| By Team Kalkine MediaHighlights,Sigma Healthcare reports a 67% drop in interim earnings due to merger costs with Chemist Warehouse.,Chemist Warehouse achieved strong growth with a net profit of $540 million for FY2024.,The ACCC's decision on the Sigma-Chemist Warehouse m...
Lumos Diagnostics Expands Reach in the U.S. with National Contract for FebriDx
September 25, 2024 06:05 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics secures a national contract with MediGroup for its FebriDx test in the U.S.,FebriDx delivers results in 10 minutes using a fingerstick blood sample, aiding quick diagnosis.,Lumos shares increased by 10.29% following the c...
Singular Health Surges 117% Year-to-Date as Key Investors Join
September 24, 2024 05:24 PM AEST| By Team Kalkine MediaIn a notable year for Singular Health (ASX:SHG), the medical imaging technology company has experienced a substantial rise of approximately 117% year-to-date. This growth has been bolstered by the support of significant investors, including Craig Sel...
Promising Innovations from Five ASX Biotech Pioneers
September 24, 2024 05:23 PM AEST| By Team Kalkine MediaMorgans senior analyst Scott Power initiated the Health Invest 2024 event, held in Sydney, with a comprehensive overview of the biotechnology and life sciences sectors to an audience that included both professional and retail investors. Power highlig...
Health Kick Podcast: PharmAust Tackles MND and ALS with Lead Drug Monepantel
September 24, 2024 05:22 PM AEST| By Team Kalkine MediaStockhead’s health and biotech expert, Tim Boreham, returns to the studio for another episode of the Health Kick Podcast. In this installment, Boreham engages in a conversation with Dr. Michael Thurn, the Managing Director at PharmAust (ASX:PAA).,Pha...
CSL (ASX:CSL) Faces Pressure, But Bell Potter Sees Buying Opportunity
September 24, 2024 01:48 PM AEST| By Team Kalkine MediaCSL Ltd (ASX:CSL) has experienced a challenging September, with its share price dropping more than 6% since the start of the month. In contrast, the ASX 200 index has recorded a modest gain of approximately 1% during the same timeframe. This decline...
Analyzing the Performance of CSL Ltd and Pro Medicus Limited in 2024
September 24, 2024 12:54 PM AEST| By Team Kalkine MediaAs of now, the share price of CSL Ltd has increased by 0.7% since the beginning of 2024, while Pro Medicus Limited is currently 1.2% shy of its 52-week high. This article explores the recent performance and fundamentals of both,ASX healthcare stocks,...
Actinogen Medical Accelerates Alzheimer’s Treatment Trials, Aiming for Fast-Track Global Approvals
September 24, 2024 12:42 PM AEST| By Team Kalkine MediaActinogen Medical (ASX:ACW) is making significant strides in the development of a novel oral treatment targeting Alzheimer’s disease and associated depression. The company is ramping up its clinical trials with fresh capital, positioning itself for a...
Immutep Ltd (ASX:IMM) Secures A$3.6 Million R&D Tax Incentive from French Government
September 24, 2024 10:48 AM AEST| By Team Kalkine MediaImmutep Ltd (ASX:IMM), a prominent player in the biotechnology sector, has successfully secured a Research and Development (R&D) Tax Incentive valued at approximately A$3.6 million from the French government. This financial support is intended to acc...
An In-Depth Analysis of CSL Shares
September 23, 2024 06:42 PM AEST| By Team Kalkine MediaThe CSL Ltd (ASX:CSL) share price has increased by 1.9% since the beginning of 2024. This article delves into the key reasons behind the recent developments in CSL shares and the broader trends influencing the healthcare sector.,CSL Overview,CSL is a...
Healius Limited (ASX: HLS) Takes Steps Towards Enhanced Shareholder Value
September 23, 2024 06:18 PM AEST| By Team Kalkine MediaHealius Limited is in the spotlight as activist investor Tanarra Capital aims to unlock greater value for shareholders following the recent sale of its imaging business, Lumus, for $835 million to private equity firm Affinity Equity Partners. This st...
EZZ Life Science (ASX: EZZ) Partners with Australian Open to Expand in Asia
September 23, 2024 05:13 PM AEST| By Team Kalkine MediaEZZ Life Science Holdings Limited (ASX: EZZ) has entered into a three-year regional sponsorship agreement with the Australian Open, starting in 2025. This partnership is a strategic move for this,ASX healthcare stock,, aimed at expanding the company’...
Healius (ASX:HLS) Shares Swing Following Major Asset Sale Announcement
September 23, 2024 01:25 PM AEST| By Team Kalkine MediaHealius Ltd (ASX:HLS), a prominent player in the Australian healthcare sector, is experiencing significant volatility in its share price following the announcement of a major asset sale. After closing Friday at AU$1.61, shares surged by 6.5% in early...
Telix Pharmaceuticals (ASX:TLX) Acquires RLS in Major US Expansion, Shares Decline Amid Market Weakness
September 23, 2024 01:11 PM AEST| By Team Kalkine MediaTelix Pharmaceuticals Ltd (ASX:TLX) is making headlines with its recent acquisition of RLS Group for AU$ 230 million in cash, along with a potential deferred cash consideration of up to $20 million. Despite this significant move to strengthen its pos...
Healius Divests Lumus Imaging in $965 Million Deal to Reduce Debt
September 23, 2024 10:05 AM AEST| By Team Kalkine MediaHealius Limited (ASX:HLS) has announced plans to divest Lumus Imaging for a substantial sum of $965 million. The deal, which is set to pay down debt and generate returns for investors, is being executed with Affinity Equity Partners, an Asian private...
Telix Pharmaceuticals Expands North American Operations with RLS Acquisition
September 23, 2024 09:52 AM AEST| By Team Kalkine MediaTelix Pharmaceuticals Ltd (ASX:TLX), based in Melbourne, is set to significantly expand its presence in North America through the acquisition of RLS Inc., the only US radiopharmacy network accredited by the Joint Commission. This strategic move will...
Advertise your brand on Kalkine Media